Quinolone resistance is associated with increased risk of invasive illness or death during infection with Salmonella serotype Typhimurium

J Infect Dis. 2004 Nov 1;190(9):1652-4. doi: 10.1086/424570. Epub 2004 Sep 21.

Abstract

In a registry-based cohort study, we determined the risk of invasive illness or death associated with infection with quinolone-resistant Salmonella serotype Typhimurium. We linked data from the Danish surveillance registry of enteric pathogens with data from the Danish civil registration system and 2 national health registries. Of 1323 patients infected with Salmonella Typhimurium, 46 (3.5%) were hospitalized due an invasive illness within 90 days of infection, and 16 (1.2%) died within 90 days of infection. After adjustment for age, sex, and comorbidity, infection with quinolone-resistant Salmonella Typhimurium was associated with a 3.15-fold (95% confidence interval, 1.39-7.10-fold) higher risk of invasive illness or death within 90 days of infection, compared with that observed for infection with pansusceptible strains.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Cohort Studies
  • Denmark
  • Drug Resistance, Bacterial
  • Female
  • Humans
  • Male
  • Quinolones / pharmacology*
  • Risk Assessment
  • Salmonella Infections / epidemiology*
  • Salmonella Infections / microbiology*
  • Salmonella Infections / mortality
  • Salmonella typhimurium / drug effects*
  • Salmonella typhimurium / pathogenicity
  • Time Factors
  • Virulence

Substances

  • Anti-Bacterial Agents
  • Quinolones